Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma

Sorafenib, a multi-tyrosine kinase inhibitor, is a standard treatment for advanced hepatocellular carcinoma (HCC). The present study was undertaken to determine whether the growth and metastasis of HCC were influenced in mice receiving sorafenib prior to implantation with tumors, and to investigate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhang, Qiang-Bo, Sun, Hui-Chuan, Zhang, Ke-Zhi, Jia, Qing-An, Bu, Yang, Wang, Miao, Chai, Zong-Tao, Zhang, Quan-Bao, Wang, Wen-Quan, Kong, Ling-Qun, Zhu, Xiao-dong, Lu, Lu, Wu, Wei-Zhong, Wang, Lu, Tang, Zhao-You
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3568028/
https://ncbi.nlm.nih.gov/pubmed/23409093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0055945
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados